Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200056798Phase 4Recruiting
Phase 4, randomised trial of wushe zhiyang wan in chronic idiopathic urticaria (CIU) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Improvement in 7-day itch severity score (ISS7) over 28 days. Started Aug 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200056798.